Cargando…

Fibroblast growth factor 23 but not copeptin is independently associated with kidney failure and mortality in patients with chronic kidney disease

BACKGROUND: Copeptin and intact fibroblast growth factor 23 (iFGF23) increase early during chronic kidney disease (CKD) and may be predictive of unfavourable outcomes. The aim of this study was to evaluate their respective associations with renal and vital outcomes in CKD patients. METHODS: We inclu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michon-Colin, Arthur, Metzger, Marie, Bankir, Lise, Gauci, Cédric, Brunel, Mélanie, Baron, Stéphanie, Prot-Bertoye, Caroline, Stengel, Bénédicte, Thervet, Eric, Haymann, Jean-Philippe, Boffa, Jean-Jacques, Vrtovsnik, François, Flamant, Martin, Houillier, Pascal, Prie, Dominique, Courbebaisse, Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689138/ https://www.ncbi.nlm.nih.gov/pubmed/38046034 http://dx.doi.org/10.1093/ckj/sfad149

Ejemplares similares

Renal Function Can Improve at Any Stage of Chronic Kidney Disease
por: Weis, Lise, et al.
Publicado: (2013)

The Relation of Hepcidin to Iron Disorders, Inflammation and Hemoglobin in Chronic Kidney Disease
por: Mercadel, Lucile, et al.
Publicado: (2014)

Decrease in Urinary Creatinine Excretion in Early Stage Chronic Kidney Disease
por: Tynkevich, Elena, et al.
Publicado: (2014)

Association of plasma potassium with mortality and end-stage kidney disease in patients with chronic kidney disease under nephrologist care - The NephroTest study
por: Wagner, Sandra, et al.
Publicado: (2017)

Correction to: Association of plasma potassium with mortality and end-stage kidney disease in patients with chronic kidney disease under nephrologist care - The NephroTest study
por: Wagner, Sandra, et al.
Publicado: (2017)

Low Serum Creatine Kinase Level Predicts Mortality in Patients with a Chronic Kidney Disease
por: Flahault, Adrien, et al.
Publicado: (2016)

Association of a Low-Protein Diet With Slower Progression of CKD
por: Metzger, Marie, et al.
Publicado: (2017)

Extracellular Fluid Volume Is an Independent Determinant of Uncontrolled and Resistant Hypertension in Chronic Kidney Disease: A NephroTest Cohort Study
por: Vidal‐Petiot, Emmanuelle, et al.
Publicado: (2018)

A 3-Marker Index Improves the Identification of Iron Disorders in CKD Anaemia
por: Mercadal, Lucile, et al.
Publicado: (2014)

How to Monitor Hydration Status and Urine Dilution in Patients with Nephrolithiasis
por: Travers, Simon, et al.
Publicado: (2023)

Safety of Inulin and Sinistrin: Combining Several Sources for Pharmacovigilance Purposes
por: Bui, T-V., et al.
Publicado: (2021)

Claudins in Renal Physiology and Pathology
por: Prot-Bertoye, Caroline, et al.
Publicado: (2020)

Combining robust urine biomarkers to assess chronic kidney disease progression
por: Bienaimé, Frank, et al.
Publicado: (2023)

VITamin D supplementation in renAL transplant recipients (VITALE): a prospective, multicentre, double-blind, randomized trial of vitamin D estimating the benefit and safety of vitamin D(3) treatment at a dose of 100,000 UI compared with a dose of 12,000 UI in renal transplant recipients: study protocol for a double-blind, randomized, controlled trial
por: Courbebaisse, Marie, et al.
Publicado: (2014)

Signification of distal urinary acidification defects in hypocitraturic patients
por: Forni Ogna, Valentina, et al.
Publicado: (2017)

Kidney Function Decline and Apparent Treatment-Resistant Hypertension in the Elderly
por: Kaboré, Jean, et al.
Publicado: (2016)

Pathophysiology of copeptin in kidney disease and hypertension
por: Afsar, Baris
Publicado: (2017)

Less arterial stiffness in kidney transplant recipients than chronic kidney disease patients matched for renal function
por: Cheddani, Lynda, et al.
Publicado: (2020)

Longitudinal Bone Loss Occurs at the Radius in CKD
por: Cailleaux, Pierre-Emmanuel, et al.
Publicado: (2021)

Plasma copeptin as a predictor of kidney disease
por: Enhörning, Sofia, et al.
Publicado: (2019)

Effects of hydration on plasma copeptin, glycemia and gluco-regulatory hormones: a water intervention in humans
por: Enhörning, Sofia, et al.
Publicado: (2017)

Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease
por: Kaboré, Jean, et al.
Publicado: (2016)

Estimating Extracellular Fluid Volume in Healthy Individuals: Evaluation of Existing Formulae and Development of a New Equation
por: Faucon, Anne-Laure, et al.
Publicado: (2022)

Plasma Copeptin and Renal Outcomes in Patients With Type 2 Diabetes and Albuminuria
por: Velho, Gilberto, et al.
Publicado: (2013)

Should We Use Standard Survival Models or the Illness-Death Model for Interval-Censored Data to Investigate Risk Factors of Chronic Kidney Disease Progression?
por: Boucquemont, Julie, et al.
Publicado: (2014)

Predicting kidney failure from longitudinal kidney function trajectory: A comparison of models
por: van den Brand, Jan A. J. G., et al.
Publicado: (2019)

Is serum copeptin a modifiable biomarker in autosomal dominant polycystic kidney disease?
por: Tasneem, Moomal, et al.
Publicado: (2018)

Serum NGAL and copeptin levels as predictors of acute kidney injury in asphyxiated neonates
por: Baumert, Małgorzata, et al.
Publicado: (2016)

Copeptin is independently associated with vascular calcification in chronic kidney disease stage 5
por: Golembiewska, Edyta, et al.
Publicado: (2020)

Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes
por: Velho, Gilberto, et al.
Publicado: (2018)

Prediction of chronic kidney disease after acute kidney injury in ICU patients: study protocol for the PREDICT multicenter prospective observational study
por: Geri, Guillaume, et al.
Publicado: (2018)

Chronic Lithium Therapy and Urine-Concentrating Ability in Individuals With Bipolar Disorder: Association Between Daily Dose and Resistance to Vasopressin and Polyuria
por: Tabibzadeh, Nahid, et al.
Publicado: (2022)

Safety of meglumine gadoterate (Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic kidney disease (RESCUE study)
por: Deray, Gilbert, et al.
Publicado: (2012)

Probiotic Intake and Inflammation in Patients With Chronic Kidney Disease: An Analysis of the CKD-REIN Cohort
por: Wagner, Sandra, et al.
Publicado: (2022)

24-h Urine Collection: a Relevant Tool in CKD Nutrition Evaluation
por: Abdel-Nabey, Moustafa, et al.
Publicado: (2020)

The Good Treatment, the Bad Virus, and the Ugly Inflammation: Pathophysiology of Kidney Involvement During COVID-19
por: Le Stang, Marie-Bénédicte, et al.
Publicado: (2021)

Reversal of Arterial Stiffness and Maladaptative Arterial Remodeling After Kidney Transplantation
por: Karras, Alexandre, et al.
Publicado: (2017)

Plasma copeptin is increased and associated with smaller kidney volume in young adults born very preterm
por: Flahault, Adrien, et al.
Publicado: (2021)

Impact of age on cardiovascular drug use in patients with chronic kidney disease
por: Villain, Cédric, et al.
Publicado: (2019)

Determinants of Kidney Function and Accuracy of Kidney Microcysts Detection in Patients Treated With Lithium Salts for Bipolar Disorder
por: Tabibzadeh, Nahid, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_250i06gsnar8lfhki3iqg8se19